S. Reddy

发表

Inhibition of the mammalian target of rapamycin (mTOR) in advanced pancreatic cancer: results of two phase II studies

R. Wolff, J. Abbruzzese, D. Davis, 2010, BMC Cancer.

Purification and Identification of a Tissue-specific Repressor Involved in Serum Amyloid A1 Gene Expression*

W. Liao, Yongsheng Ren, S. Reddy, 1999, The Journal of Biological Chemistry.

Phosphatidylinositol 3-Kinase in Interleukin 1 Signaling

W. Liao, S. Reddy, Jianyi H. Huang, 1997, The Journal of Biological Chemistry.

The rapamycin analog CCI-779 is a potent inhibitor of pancreatic cancer cell proliferation.

Donghui Li, J. Abbruzzese, Takayuki Asano, 2005, Biochemical and biophysical research communications.

Identification of a protein kinase associated with the cytoplasmic domain of the p60 tumor necrosis factor receptor.

B. Aggarwal, B. Darnay, S. Reddy, 1994, The Journal of biological chemistry.

Constitutive activation of AKT pathway inhibits TNF-induced apoptosis in mitochondrial DNA-deficient human myelogenous leukemia ML-1a.

Takayuki Asano, S. Reddy, A. Naito, 2008, Cancer letters.

Curcumin is a non‐competitive and selective inhibitor of phosphorylase kinase

B. Aggarwal, S. Reddy, 1994, FEBS letters.

Tumor Suppressor MMAC/PTEN Inhibits Cytokine-induced NFκB Activation without Interfering with the IκB Degradation Pathway*

W. Yung, J. Abbruzzese, D. Koul, 2001, The Journal of Biological Chemistry.

Alleviating the Suppression of Glycogen Synthase Kinase-3β by Akt Leads to the Phosphorylation of cAMP-response Element-binding Protein and Its Transactivation in Intact Cell Nuclei*

S. Lippman, J. Clifford, A. Kikuchi, 2003, Journal of Biological Chemistry.

Phosphatidylinositol 3-Kinase as a Mediator of TNF-Induced NF-κB Activation1

W. Liao, S. Reddy, Jianyi H. Huang, 2000, The Journal of Immunology.

Phosphatidylinositol 3-Kinase as a Mediator of TNF-Induced NF-kB Activation

W. Liao, S. Reddy, Jianyi H. Huang, 2000 .

Resistance of Human Ovarian Cancer Cells to Tumor Necrosis Factor (cid:1) Is a Consequence of Nuclear Factor (cid:2) B-Mediated Induction of Fas-Associated Death Domain-Like Interleukin-1 (cid:3) -Converting Enzyme-Like Inhibitory Protein

B. Tsang, Xiaojuan Yan, S. Reddy, 2003 .

Resistance of human ovarian cancer cells to tumor necrosis factor alpha is a consequence of nuclear factor kappaB-mediated induction of Fas-associated death domain-like interleukin-1beta-converting enzyme-like inhibitory protein.

B. Tsang, Xiaojuan Yan, C. Xiao, 2003, Endocrinology.

Physical and functional association of a serine-threonine protein kinase to the cytoplasmic domain of the p80 form of the human tumor necrosis factor receptor in human histiocytic lymphoma U-937 cells.

B. Aggarwal, B. Darnay, S. Reddy, 1994, The Journal of biological chemistry.

The PI 3-kinase/Akt signaling pathway is activated due to aberrant Pten expression and targets transcription factors NF-κB and c-Myc in pancreatic cancer cells

Yixin Yao, Donghui Li, J. Abbruzzese, 2004, Oncogene.

Tocotrienols inhibit AKT and ERK activation and suppress pancreatic cancer cell proliferation by suppressing the ErbB2 pathway.

W. Stone, K. Krishnan, S. Reddy, 2011, Free radical biology & medicine.

c-Jun promotes cellular survival by suppression of PTEN

K. Sabapathy, F. Vikhanskaya, I. Belle, 2007, Cell Death and Differentiation.

Hdm2 is regulated by K-Ras and mediates p53-independent functions in pancreatic cancer cells

J. Abbruzzese, S. Shin, X. Sui, 2009, Oncogene.

Establishment of three-dimensional cultures of human pancreatic duct epithelial cells.

J. Abbruzzese, D. Menter, S. Reddy, 2007, Biochemical and biophysical research communications.

Hypothesis Generation in Signaling Networks

Luay Nakhleh, M. Sriram Iyengar, Prahlad T. Ram, 2006, J. Comput. Biol..

BSTA Promotes mTORC2-Mediated Phosphorylation of Akt1 to Suppress Expression of FoxC2 and Stimulate Adipocyte Differentiation

Milind B. Suraokar, G. Mills, Yiling Lu, 2013, Science Signaling.

PTEN down regulates AP-1 and targets c-fos in human glioma cells Via PI3-kinase/Akt pathway

B. Aggarwal, W. Yung, K. Bhat, 2007, Molecular and Cellular Biochemistry.

Activator Protein-1 Has an Essential Role in Pancreatic Cancer Cells and Is Regulated by a Novel Akt-Mediated Mechanism

M. Korc, K. Sabapathy, J. Abbruzzese, 2007, Molecular Cancer Research.

Purification and Characterization of the Serum Amyloid A3 Enhancer Factor*

W. Liao, Yongsheng Ren, S. Reddy, 1999, The Journal of Biological Chemistry.

Insulin receptor substrate is a mediator of phosphoinositide 3-kinase activation in quiescent pancreatic cancer cells.

J. McCubrey, J. Abbruzzese, Takayuki Asano, 2005, Cancer research.

The IL-1 receptor accessory protein is essential for PI 3-kinase recruitment and activation.

W. Liao, Helen J. Huang, Yu-Feng Lin, 2004, Biochemical and biophysical research communications.

Reconstitution of nuclear factor kappa B activation induced by tumor necrosis factor requires membrane-associated components. Comparison with pathway activated by ceramide.

B. Aggarwal, M. Chaturvedi, B. Darnay, 1994, The Journal of biological chemistry.

Resistance of Human Ovarian Cancer Cells to Tumor Necrosis Factor α Is a Consequence of Nuclear Factor κB-Mediated Induction of Fas-Associated Death Domain-Like Interleukin-1β-Converting Enzyme-Like Inhibitory Protein

B. Tsang, Xiaojuan Yan, C. Xiao, 2003 .

The PI 3-kinase/Akt signaling pathway is activated due to aberrant Pten expression and targets transcription factors NF-κB and c-Myc in pancreatic cancer cells

Yixin Yao, Donghui Li, J. Abbruzzese, 2005, Oncogene.

Phosphatidylinositol 3-kinase as a mediator of TNF-induced NF-kappa B activation.

W. Liao, S. Reddy, J. Huang, 2000, Journal of immunology.

Tumor suppressor MMAC/PTEN inhibits cytokine-induced NFkappaB activation without interfering with the IkappaB degradation pathway.

W. Yung, J. Abbruzzese, D. Koul, 2001, The Journal of biological chemistry.

Constitutive activation of AKT pathway inhibits TNF-induced apoptosis in mitochondrial DNA-deficient human myelogenous leukemia ML-1a.

Takayuki Asano, S. Reddy, A. Naito, 2008, Cancer letters.